Hyperbilirubinemia, also referred to as neonatal jaundice is a very common problem in newborns. It is a disorder in which level of bilirubin in the blood become high. Bilirubin is a substance, which is formed in the blood when the red blood cells breakdown. Treatment of the bilirubin is not easy in newborns. Moreover, it can increase fluids and other tissues of the baby's body. It is curable and revocable, if appropriately treated. However, its aggravation could cause sequela into the central nervous system, which could lead to the patient’s death. According to statistics published by the National Center for Biotechnology Information, nearly 60% to 80% of healthy newborns are prone to develop hyperbilirubinemia. Therefore, the demand for hyperbilirubinemia treatment is expected to rise along with the growing prevalence of neonatal jaundice.
On the basis of the treatment, the global hyperbilirubinemia treatment market can be segmented into
- Fiberoptic blanket
- Exchange transfusion
Increasing incidence of newborn jaundice and technological advancements across developed and developing countries in order to treat hyperbilirubinemia is expected to drive the growth of the hyperbilirubinemia treatment market over the forecast period. Furthermore, efficient treatment systems and high-cost treatments in low and middle-income countries could challenge the growth of the market. Phototherapy treatment is a preferred treatment for newborns. It is considered to be an effective treatment for hyperbilirubinemia. This treatment involves emission of blue light over the patient’s skin, which converts high-risk bilirubin molecules into less toxic isomeric forms in the blood, by using photoisomerization and photo-oxidation. High power LEDs devices are used for highly efficient treatment and negligible emission of UV/ IR radiation. The LED lights cost less as compared to the conventional phototherapy equipment. These lights have been proven to be very effective in the treatment of neonatal jaundice having a long-lasting effect. Therefore, development in this technology can impact the growth of the market. Rising adoption of these LED-based phototherapy equipment can further accelerated the growth of hyperbilirubinemia treatment market. However, significant use of alternative methods of treatments and strict regulatory policies for the approval of new treatment equipment and therapeutics are limiting the growth of the market.
Depending upon the regions, the global hyperbilirubinemia treatment market is segmented into North America, Europe, Asia-pacific, Latin America, and Middle East & Africa. North America accounts for the most of the market, followed by Europe owing to penetration of advanced technology in the field of hyperbilirubinemia treatment and increased awareness among the people towards the use of new technologies. However, Asia-Pacific is expected to experience a high growth rate over the forecast period. Strategic expansion by key market players in the emerging economies, growing acceptance of the low-cost phototherapy equipment in China and India, and the rising number of patients suffering from hyperbilirubinemia are key factors impelling for the growth of the hyperbilirubinemia treatment market in the Asia-Pacific region. Additionally, rapidly evolving healthcare infrastructure in this region is expected to provide a robust growth of the global hyperbilirubinemia treatment market.
Major players operating in the global hyperbilirubinemia treatment market include Favero Health Projects Spa, Koninklijke Philips, N.V., GE Healthcare, Natus Medical Incorporated, Honle UV America, Inc., Nice Neotech Medical Systems Private, Ltd., Phoenix Medical Systems Pvt. Ltd., Herbert Waldmann GmbH & Co. KG, Arjo Huntlleigh, and Solarc Systems, Inc.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.